CIK 0001372299
- Non-accelerated filer
- Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Open-market sale Director sold 149,700 shares at $15.75 ($2,357,775)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at $11.07 ($110,700)
- 4 Open-market sale Director sold 71,371 shares at an average $10.12 ($722,299)
- 4 Open-market sale Director sold 1,898 shares at $9.01 ($17,101)
- 4 Open-market sale Director sold 201,731 shares at an average $8.42 ($1,697,614)
- 4 Open-market sale Director sold 7,500 shares at $8.13 ($60,975)
- 4 Open-market sale Chief Executive Officer sold 125,000 shares at $9.80 ($1,225,000)
- 4 Open-market sale Chief Financial Officer sold 7,990 shares at $9.96 ($79,580)
- 4 Open-market sale Chief Executive Officer sold 125,000 shares at $7.52 ($940,000)
- 4 Open-market sale Chief Financial Officer sold 30,000 shares at $7.22 ($216,600)
- 4 Open-market sale Director sold 10,000 shares at $6.81 ($68,072)
- 4 Open-market sale Director sold 7,500 shares at $6.40 ($48,000)
- 4 Open-market sale Chief Financial Officer sold 31,086 shares at $6.70 ($208,276)
- 4 Open-market sale Director sold 10,000 shares at $8.13 ($81,345)
- 4 Open-market sale Chief Financial Officer sold 31,000 shares at $7.00 ($217,000)
- 4 Open-market sale Director sold 68,185 shares at $8.86 ($604,119)
- 4 Open-market sale Chief Executive Officer sold 30,558 shares at an average $10.97 ($335,217)
- 4 Open-market sale Director sold 10,000 shares at $10.00 ($100,000)
- 4 Open-market sale Director sold 7,191 shares at $8.82 ($63,417)
- 4 Open-market sale Director sold 33,500 shares at an average $8.20 ($274,755)
Page 6 of 15 · 288 filings